Discovery of Dual Orexin Receptor Antagonists (DORAs) for the Treatment of Insomnia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|6|696-725

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.6, 2011-03, pp. : 696-725

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypocretin Antagonists in Insomnia Treatment and Beyond

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1476-1482

Bentham Science Publishers

Access to resources Recommend Favorite

Orexin Receptor Antagonists: Medicinal Chemistry and Therapeutic Potential

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 11, 2008-07 ,pp. : 977-987

Bentham Science Publishers

Access to resources Recommend Favorite

Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3438-3469

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity

By Rokosz Laura L  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1301-1327

Informa Healthcare

Access to resources Recommend Favorite

Histamine H Receptor Antagonists in the Treatment of Insomnia: Is There a Rational Basis for Use?

By Monti J.M.  

CNS Drugs, Vol. 13, Iss. 2, 2000-02 ,pp. : 87-96

Adis International

Access to resources Recommend Favorite